Change Makers: Richard Francis on the Pillars of Innovation and Growth
One in every 13 prescriptions in the US is a generic from Teva. Now, CEO Richard Francis is focusing on drug development, delivering better medications faster.
One in every 13 prescriptions in the US is a generic from Teva. Now, CEO Richard Francis is focusing on drug development, delivering better medications faster.
In a recent Cleveland Clinic study of patients with class III obesity who had an unscheduled C-section delivery, those who received a standard dose of…
Two new trials published in JAMA evaluate the efficacy of periprocedural intra-arterial thrombolytics after successful endovascular thrombectomy for patients with acute ischemic stroke. Diederik Dippel,…
This study assesses the association of citywide doxycycline postexposure prophylaxis guideline release with reported chlamydia, gonorrhea, and early syphilis cases in men who have sex…
I wrote about CES 2025 from the comfort of my home, but a selection of really cool gadgets made me sad I didn’t attend the…
The digital health sector raked in $10.1 billion in venture funding in 2024, down from $10.8 billion in 2023 but higher than 2019’s funding total.…
When Donald Trump pledges in next Monday’s inauguration to “faithfully execute the office of President of the United States”, global economics and politics will take…
CES offers a glimpse of the latest shiny gadgets, but companies also show off forward-looking concepts that are still in the works. Here are some…
A recent federal ruling is expected to help nursing home residents with disabilities receive long term care at home.
Japan’s population is the oldest in the world, with few young people working in agriculture. But now its farmers are getting help from a robot…
Nature Communications – This study demonstrates how point defects in 2D semiconductors can be harnessed for neuromorphic computing. By using random telegraph noise in WSe2…